ENTO has been in the news 409% more than usual
Apr 25, 2025, 10:32 AM
5.47%
What does ENTO do
First Wave Biopharma, headquartered in Boca Raton, Florida, develops nonsystemic therapies for gastrointestinal diseases and went public in October 2016. Its key programs include latiglutenase, capeserod, and adrulipase.
ENTO has been in the news recently: The Gross Law Firm and other legal entities are notifying Zenas BioPharma, Inc. shareholders who purchased shares during the September 2024 IPO about a class action lawsuit concerning alleged securities fraud. Investors are encouraged to register by June 16, 2025, to seek potential recovery or compensation without fees.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.